Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Has announcements × pembrolizumab × Clear all

Phase

Status

Completed 27 Active not recruiting 12 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Metastatic Urothelial Cancer 1

Interventions

zimberelimab 1 trastuzumab deruxtecan 1 tovorafenib 1 tocilizumab 1 talquetamab 1 selinexor 1 sacituzumab govitecan 1 revumenib 1 repotrectinib 1 pralsetinib 1 pembrolizumab 1 pegaspargase 1 obinutuzumab 1 naxitamab 1 merphos 1 ivosidenib 1 ipatasertib 1 inavolisib 1 glofitamab 1 entrectinib 1 enfortumab vedotin 1 calaspargase pegol 1 belzutifan 1 avelumab 1 atezolizumab 1 asparaginase erwinia chrysanthemi recombinant 1 alectinib 1 X-Rays 1 Vincristine 1 Spinal Puncture 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03547973 2026-03-16

TROPHY U-01

Gilead Sciences

Phase 2 Recruiting

827 enrolled 1 FDA

Metastatic Urothelial Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡